Neevel Andrew J, Smith Joshua D, Morrison Robert J, Hogikyan Norman D, Kupfer Robbi A, Stein Andrew P
University of Michigan Medical School, Ann Arbor, Michigan, USA.
Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan, USA.
OTO Open. 2021 Aug 24;5(3):2473974X211041040. doi: 10.1177/2473974X211041040. eCollection 2021 Jul-Sep.
Patients with COVID-19 are at risk for laryngeal injury and dysfunction secondary to respiratory failure, prolonged intubation, and other unique facets of this illness. Our goal is to report clinical features and treatment for patients presenting with voice, airway, and/or swallowing concerns postacute COVID-19.
Case series.
Academic tertiary care center.
Patients presenting with laryngeal issues following recovery from COVID-19 were included after evaluation by our laryngology team. Data were collected via retrospective chart review from March 1, 2020, to April 1, 2021. This included details of the patient's COVID-19 course, initial presentation to laryngology, and subsequent treatment.
Twenty-four patients met inclusion criteria. Twenty (83%) patients were hospitalized, and 18 required endotracheal intubation for a median (range) duration of 14 days (6-31). Ten patients underwent tracheostomy. Patients were evaluated at a median 107 days (32-215) after their positive SARS-CoV-2 test result. The most common presenting concerns were dysphonia (n = 19, 79%), dyspnea (n = 17, 71%), and dysphagia (n = 6, 25%). Vocal fold motion impairment (50%), early glottic injury (39%), subglottic/tracheal stenosis (22%), and posterior glottic stenosis (17%) were identified in patients who required endotracheal intubation. Patients who did not need intubation were most frequently treated for muscle tension dysphonia (67%).
Patients may develop significant voice, airway, and/or swallowing issues postacute COVID-19. These complications are not limited to patients requiring intubation or tracheostomy. Multidisciplinary laryngology clinics will continue to play an integral role in diagnosing and treating patients with COVID-19-related laryngeal sequelae.
新型冠状病毒肺炎(COVID-19)患者因呼吸衰竭、长时间插管及该疾病的其他独特方面而存在喉部损伤和功能障碍的风险。我们的目标是报告急性COVID-19后出现声音、气道和/或吞咽问题的患者的临床特征及治疗情况。
病例系列。
学术性三级医疗中心。
经我们的喉科学团队评估后,纳入从COVID-19康复后出现喉部问题的患者。通过回顾性病历审查收集2020年3月1日至2021年4月1日的数据。这包括患者COVID-19病程的详细信息、初次就诊于喉科学的情况及后续治疗。
24例患者符合纳入标准。20例(83%)患者曾住院,18例需要气管插管,中位(范围)时长为14天(6 - 31天)。10例患者接受了气管切开术。患者在SARS-CoV-2检测呈阳性后的中位107天(32 - 215天)接受评估。最常见的就诊问题是声音嘶哑(n = 19,79%)、呼吸困难(n = 17,71%)和吞咽困难(n = 6,25%)。在需要气管插管的患者中,发现声带运动障碍(50%)、早期声门损伤(39%)、声门下/气管狭窄(22%)和后声门狭窄(17%)。不需要插管的患者最常接受肌肉紧张性发声障碍的治疗(67%)。
急性COVID-19后患者可能出现严重的声音、气道和/或吞咽问题。这些并发症不限于需要插管或气管切开术的患者。多学科喉科学诊所将继续在诊断和治疗COVID-19相关喉部后遗症患者中发挥不可或缺的作用。